KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Assets Average (2016 - 2025)

West Pharmaceutical Services' Assets Average history spans 16 years, with the latest figure at $4.0 billion for Q3 2025.

  • For Q3 2025, Assets Average rose 12.48% year-over-year to $4.0 billion; the TTM value through Sep 2025 reached $4.0 billion, up 12.48%, while the annual FY2024 figure was $3.7 billion, 0.36% changed from the prior year.
  • Assets Average for Q3 2025 was $4.0 billion at West Pharmaceutical Services, up from $3.8 billion in the prior quarter.
  • Across five years, Assets Average topped out at $4.0 billion in Q3 2025 and bottomed at $2.8 billion in Q1 2021.
  • The 5-year median for Assets Average is $3.6 billion (2024), against an average of $3.5 billion.
  • The largest annual shift saw Assets Average rose 22.3% in 2021 before it decreased 4.08% in 2024.
  • A 5-year view of Assets Average shows it stood at $3.2 billion in 2021, then grew by 7.39% to $3.5 billion in 2022, then grew by 9.38% to $3.8 billion in 2023, then dropped by 3.5% to $3.7 billion in 2024, then grew by 10.11% to $4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for WST's Assets Average are $4.0 billion (Q3 2025), $3.8 billion (Q2 2025), and $3.6 billion (Q1 2025).